Try our Advanced Search for more refined results
Mergers & Acquisitions
-
December 17, 2025
Edinburgh Trust Urges Shareholders To Nix Board Takeover Bid
British investment company Edinburgh Worldwide on Wednesday urged its shareholders to vote against proposals made by its biggest shareholder Saba Capital to revamp its board, in what it called an attempt to "take control on the cheap."
-
December 17, 2025
Blackstone Seals $5B Partnership With Israeli Asset Manager
Israel-based asset management and insurance company Phoenix Financial on Wednesday announced that it has entered into a strategic partnership with Simpson Thacher & Bartlett LLP-led private equity giant Blackstone under which the Israeli firm will invest up to $5 billion across a range of credit strategies.
-
December 17, 2025
Diageo To Exit Kenya In $2.3B Deal With Asahi
Guinness owner Diageo said Wednesday that it has agreed to sell its Kenyan subsidiary to Japanese rival Asahi in a $2.3 billion deal, marking its exit from the East African country.
-
December 17, 2025
Warner Bros. Board Rejects 'Inferior' Paramount Bid
Warner Bros. Discovery Inc. said Wednesday that its board has determined Paramount Skydance Corp.'s $108.4 billion hostile offer is not a "superior proposal" to the company's pending $82.7 billion agreement with Netflix.
-
December 17, 2025
Finance Co. Gets Extra Time To Make £523M UK Credit Biz Bid
Britain's merger regulator has extended the deadline of U.S. finance group BasePoint Capital LLC to table a £523 million ($697 million) bid for International Personal Finance PLC, the U.K. credit provider said Wednesday.
-
December 17, 2025
Greencore's £1.2B Bakkavor Deal To Complete After CMA OK
Irish food manufacturer Greencore said Wednesday that it expects its £1.2 billion ($1.6 billion) acquisition of rival Bakkavor to complete in January after the U.K.'s competition authority abandoned its probe amid antitrust fixes proposed by the sides.
-
December 16, 2025
Judge Skeptical Of Trump-Tied SPAC's Defense In SEC Suit
A former Trump business associate appeared unlikely to win early dismissal of a U.S. Securities and Exchange Commission suit accusing him of hiding advanced merger discussions with the president's media company from SPAC investors in 2021, as a federal judge wondered Tuesday how the talks could be considered immaterial.
-
December 16, 2025
Va. Judge Advances Most Claims In Stelara Antitrust Case
A Virginia federal judge has allowed health insurer CareFirst's anticompetition and patent fraud claims against Johnson & Johnson to move forward in a case alleging anticompetitive behavior in relation to the immunosuppressive drug Stelara, while letting the pharmaceutical giant escape some claims of misrepresentation.
-
December 16, 2025
The Most Important Healthcare And Life Science Deals Of 2025
Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition of Metsera and transactions in outpatient services and gene therapy.
-
December 16, 2025
Trends That Shaped Healthcare Dealmaking In 2025
With 2025 coming to a close, Law360 Healthcare Authority asked attorneys focused on healthcare deals for their take on the trends that influenced dealmaking over the last 12 months.
-
December 16, 2025
PE Giant KKR Plugs $220M Into Dubai-Based Premialab
Data, analytics and risk management solutions provider Premialab, advised by A&O Shearman, on Tuesday revealed that it received a $220 million growth investment from Gibson Dunn & Crutcher LLP-led private equity giant KKR.
-
December 16, 2025
JP Morgan PE Group's Latest Fund Exceeds Target At $1.44B
J.P. Morgan Asset Management's private equity group closed its 12th flagship fund, PEG Global Private Equity XII, above its $1.25 billion target at $1.44 billion, the firm announced Tuesday.
-
December 16, 2025
Kering, Ardian Form $900M JV At Luxury NYC Property
French luxury group Kering said Tuesday it has completed another real estate joint venture with private equity firm Ardian, expanding a partnership launched earlier this year with a $900 million deal for a Fifth Avenue retail property in New York City.
-
December 15, 2025
Del. Justices Put ITG On Hook For $250M Reynolds Settlement
Delaware's Supreme Court stubbed out an eight-year ITG Brands LLC legal battle to avoid paying R.J. Reynolds more than $250 million to cover health-related settlement payments to Florida after ITG's acquisition of four of the cigarette company's brands, according to a ruling issued Monday.
-
December 15, 2025
Fast-Track Sale Timeline Denied In Furniture Co. Ch. 11
A Delaware bankruptcy judge rejected an expedited timeline for the sale of the assets of home furnishing retailer American Signature Furniture, finding that the proposed 34-day process would not give enough time for an investigation of insider claims and the appointment of a consumer privacy ombudsman.
-
December 15, 2025
Cencora Pays $5B For Majority Stake Of OneOncology
Pharmaceutical company Cencora Inc. unveiled plans Monday to acquire a majority stake in cancer care company OneOncology for $5 billion, buying interest from private equity shop TPG in a deal built by three law firms.
-
December 15, 2025
Juventus Rejects Crypto Firm Tether's Bid, Stock Soars
The owners of Italian football club Juventus rejected an unsolicited buyout bid from crypto firm Tether, saying there is "no intention" of selling shares and helping to push the club's market capitalization above $1 billion as its stock surged Monday.
-
December 15, 2025
Investment Firms Nab Quipt Home Medical In $260M Deal
Medical equipment provider Quipt Home Medical Corp. on Monday announced plans to go private after being purchased by a special purpose acquisition vehicle funded by investment firms Kingswood Capital Management and Forager Capital Management in a deal that values the company at $260 million and was built by three law firms.
-
December 15, 2025
Catching Up With Delaware's Chancery Court
Litigation in Delaware's Court of Chancery sprawled from a dispute over control of banana plantations along Africa's Congo River to a fight over the late musician Prince's estate last week. Along the way, a court ruling rejected a motion for a quick decision favoring Blue Bell Creameries director and officer calls for liability releases in a tainted ice cream saga that dates to 2015.
-
December 15, 2025
Europe Seen As Top Tech M&A Prospect For 2026
Europe has quietly become tech dealmakers' top hunting ground, as global tech mergers and acquisitions values skyrocketed more than 72% in the first three quarters of the year, according to a new global survey from Morrison Foerster LLP.
-
December 15, 2025
McDermott-Led Sobi To Buy US Gout Specialist For $1.5B
Swedish biopharma company Swedish Orphan Biovitrum AB said Monday that it has agreed to acquire Arthrosi Therapeutics Inc., a specialist in treatment for gout, for up to $1.5 billion in a deal guided by McDermott.
-
December 12, 2025
Live Nation Consumers Get Class Certified In Antitrust Case
A California federal judge Friday certified a class of consumers accusing Live Nation of monopolizing the live entertainment industry, rejecting the company's argument that there aren't common issues that predominate over individual ones and adopting a tentative ruling he issued earlier this month.
-
December 12, 2025
Printing Co. Defends Trial Win In $265M ESOP Sale Dispute
A printing company's directors and employee stock ownership plan trustee say the Seventh Circuit should back their win over accusations they illegally undersold the company into private equity for $265 million, arguing the trial court correctly decided their interests were "perfectly aligned" with plan participants' interests.
-
December 12, 2025
Prospect Medical Wins OK For Chapter 11 Plan
A Texas bankruptcy judge approved Prospect Medical Holdings Inc.'s Chapter 11 plan after overruling a slew of objections during an all-day hearing Friday and allowing the healthcare group to hand off its remaining hospitals and pursue litigation to repay creditors.
-
December 12, 2025
Wrong Metric Created $2 Valuation, Chancery Suit Says
A former equity holder in a nutrition services business has sued in Delaware Chancery Court seeking to unwind what it calls a sham $2 repurchase of its ownership interest and to force payment of a separate $2 million deferred purchase price, arguing that the business disregarded contractually mandated valuation mechanics to engineer a zero-value outcome.
Expert Analysis
-
Opinion
Premerger Settlements Don't Meet Standard For Bribery
Claims that Paramount’s decision to settle a lawsuit with President Donald Trump while it was undergoing a premerger regulatory review amounts to a quid pro quo misconstrue bribery law and ignore how modern legal departments operate, says Ediberto Román at the Florida International University College of Law.
-
Series
Playing Soccer Makes Me A Better Lawyer
Soccer has become a key contributor to how I approach my work, and the lessons I’ve learned on the pitch about leadership, adaptability, resilience and communication make me better at what I do every day in my legal career, says Whitney O’Byrne at MoFo.
-
Series
Law School's Missed Lessons: Learning From Failure
While law school often focuses on the importance of precision, correctness and perfection, mistakes are inevitable in real-world practice — but failure is not the opposite of progress, and real talent comes from the ability to recover, rethink and reshape, says Brooke Pauley at Tucker Ellis.
-
Legal Ops, Compliance Increasingly Vital To Antitrust Strategy
With deal timelines tightening and disclosure requirements intensifying, legal operations and compliance teams are becoming critical drivers of premerger strategy, cross-functional alignment and regulatory credibility, says Alexander Lima at Wesco International.
-
Series
Adapting To Private Practice: From ATF Director To BigLaw
As a two-time boomerang partner, returning to BigLaw after stints as a U.S. attorney and the director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, people ask me how I know when to move on, but there’s no single answer — just clearly set your priorities, says Steven Dettelbach at BakerHostetler.
-
4th Circ. Favors Plain Meaning In Bump-Up D&O Ruling
The Fourth Circuit's latest denial of indemnity coverage in Towers Watson v. National Union Fire Insurance and its previous ruling in this case lay out a pragmatic approach to bump-up provisions that avoids hypertechnical constructions to limit the effect of a policy's plain meaning, say attorneys at Kennedys.
-
Opinion
DOJ's HPE-Juniper Settlement Will Help US Compete
The U.S. Department of Justice settlement with Hewlett Packard Enterprise clears the purchase of Juniper Networks in a deal that positions the U.S. as a leader in secure, scalable networking and critical digital infrastructure by requiring the divestiture of a WiFi network business geared toward small firms, says John Shu at Taipei Medical University.
-
Series
Playing Baseball Makes Me A Better Lawyer
Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.
-
Building Better Earnouts In The Current M&A Climate
In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.
-
Series
Law School's Missed Lessons: Skillful Persuasion
In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.
-
A Look At Trump 2.0 Antitrust Enforcement So Far
The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.
-
Litigation Inspiration: How To Respond After A Loss
Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.
-
Series
Playing Mah-Jongg Makes Me A Better Mediator
Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.